Shanghai ZJ Bio-Tech Co., Ltd

Equities

688317

CNE100005DB6

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 06:00:00 2024-05-20 pm EDT 5-day change 1st Jan Change
16.1 CNY -1.53% Intraday chart for Shanghai ZJ Bio-Tech Co., Ltd -1.35% -23.26%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Shanghai ZJ Bio-Tech Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024. CI
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Shanghai ZJ Bio-Tech Co., Ltd. announces an Equity Buyback for CNY 70 million worth of its shares. CI
Shanghai ZJ Bio-Tech Co., Ltd. authorizes a Buyback Plan. CI
Certain A Shares of Shanghai ZJ Bio-Tech Co., Ltd. are subject to a Lock-Up Agreement Ending on 19-JAN-2024. CI
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shanghai ZJ Bio-Tech Chairman to Buy 15 Million Yuan More Shares MT
Shanghai ZJ Bio-Tech Co., Ltd.'s Equity Buyback announced on May 6, 2022 has expired. CI
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tranche Update on Shanghai ZJ Bio-Tech Co., Ltd.'s Equity Buyback Plan announced on May 6, 2022. CI
Shanghai ZJ Bio-Tech Co., Ltd.(XSSC:688317) added to S&P Global BMI Index CI
Shanghai ZJ Bio-Tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Tranche Update on Shanghai ZJ Bio-Tech Co., Ltd.'s Equity Buyback Plan announced on May 6, 2022. CI
CJ Cheiljedang Corporation completed the acquisition of 15.99% stake in ChunLab, Inc. from Jong-sik Cheon and Shanghai ZJ Bio-Tech Co., Ltd.. CI
CJ Cheiljedang Corporation signed a stock purchase contract to acquire 15.99% stake in ChunLab, Inc. from Jong-sik Cheon and Shanghai ZJ Bio-Tech Co., Ltd. for KRW 25 billion. CI
Chart Shanghai ZJ Bio-Tech Co., Ltd
More charts
Shanghai ZJ Bio-Tech Co Ltd is a China-based company that mainly engaged in the production of molecular diagnostic reagents. The Company is mainly engaged in the research, development, production and sales of genetic diagnostic reagents and equipment. The Company's main products include nucleic acid detection kits and molecular diagnostic instruments. The Company's products are mainly used in areas such as emergency public health safety, medical clinical diagnosis, entry-exit inspection and quarantine, and food safety. The Company mainly conducts business within the domestic market.
More about the company
  1. Stock Market
  2. Equities
  3. 688317 Stock
  4. News Shanghai ZJ Bio-Tech Co., Ltd
  5. Shanghai ZJ Bio-Tech Chairman to Buy 15 Million Yuan More Shares
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW